Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trialGuoying Liu, Yan‐Qun Xiang, Tian-Sheng Gao et al.|BMJ|2024Cited by 17
Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results databaseZhenfei Xiang, Yan‐Qun Xiang, Danfei Hu et al.|Oral Oncology|2021Cited by 16
Benefit of chemotherapy differs in node-negative and node-positive stage III nasopharyngeal carcinoma: analysis of the SEER databaseZhenfei Xiang, Yan‐Qun Xiang, Wang‐Zhong Li et al.|Research Square|2021Cited by 0